Risk USA: Margin for OTC products is too high, says Pimco's De Leon

Healthy options

Incoming margin regimes for over-the-counter derivatives are too high, while those for the futures market may be too low, according to William De Leon, global head of portfolio risk management at Pimco - and the too-high OTC margin requirements could distort markets for eligible collateral.

The issue hinges on assumptions about how long it will take a central counterparty (CCP) to liquidate the portfolio of a defaulted member or client. That assumption drives the amount of initial margin a clear

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: